FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 44 filers reported holding FENNEC PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.07 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,169 | +173.9% | 422 | +222.1% | 0.00% | – |
| Q2 2023 | $1,157 | -37.9% | 131 | -41.5% | 0.00% | – |
| Q1 2023 | $1,864 | +73.4% | 224 | +100.0% | 0.00% | – |
| Q4 2022 | $1,075 | +7.5% | 112 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 112 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 112 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | – | 112 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Solas Capital Management, LLC | 849,979 | $3,400,000 | 3.47% |
| Southpoint Capital Advisors LP | 3,997,214 | $15,989,000 | 0.60% |
| Opaleye Management Inc. | 295,000 | $1,180,000 | 0.36% |
| 683 Capital Management, LLC | 971,351 | $3,885,000 | 0.35% |
| Avoro Capital Advisors LLC | 1,105,999 | $4,424,000 | 0.15% |
| Eventide Asset Management | 720,000 | $2,880,000 | 0.09% |
| Granahan Investment Management | 439,083 | $1,756,000 | 0.09% |
| Hartford Financial Management Inc. | 20,300 | $81,000 | 0.03% |
| OXFORD ASSET MANAGEMENT LLP | 75,236 | $301,000 | 0.01% |
| Paloma Partners Management Co | 54,400 | $218,000 | 0.00% |